help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BLOOR, C. A.
Right arrow Articles by ALLEN, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BLOOR, C. A.
Right arrow Articles by ALLEN, J. T.

Am. J. Respir. Crit. Care Med., Volume 164, Number 2, July 2001, 265-272

Differential mRNA Expression of Insulin-like Growth Factor-1 Splice Variants in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis

CLAIRE A. BLOOR, RICHARD A. KNIGHT, RAVINDRA K. KEDIA, MONICA A. SPITERI, and JEREMY T. ALLEN

Lung Injury and Inflammation Research Group, Directorate of Respiratory Medicine, North Staffordshire Hospital, Stoke-on-Trent, United Kingdom

Insulin-like growth factor-1 (IGF-1) is a highly mitogenic polypeptide detectable in human lung. Using competitive reverse transcriptase/polymerase chain reaction (RT-PCR), expression of four IGF-1 transcripts was examined in bronchoalveolar lavage cells (BALC) from normal subjects, idiopathic pulmonary fibrosis (IPF), stage I/II (no fibrosis), and stage III/IV (confirmed fibrosis) pulmonary sarcoidosis patients, and fibroblast strains isolated from normal and IPF lungs. Transcripts studied were Class 1 and Class 2 (exons 1 or 2, respectively) with IGF-1Eb or IGF-1Ea (exons 5 or 6, respectively). Total IGF-1 expression was downregulated in BALC of both patients with IPF (p < 0.01) and patients with sarcoidosis (p < 0.04) compared with healthy subjects. In contrast, both constitutive (p < 0.003) and transforming growth factor-beta (TGF-beta )- induced (p < 0.02) IGF-1 expression was higher in fibrotic, compared with normal, fibroblasts. These changes were associated with differential expression of IGF-1 splice variants. Healthy subjects and sarcoidosis patients without fibrosis showed similar expression of Class 1/Class 2 and IGF-1Ea/IGF-1Eb. However, patients with fibrosis demonstrated discordant, increased relative abundance of Class 1 transcripts (p < 0.01). In parallel, all fibrosis patients failed to express Class 2, IGF-1Eb forms and sarcoidosis patients with fibrosis did not express the Class 1, IGF-1Eb variant either. Fibrotic fibroblasts expressed higher constitutive levels of Class 1, IGF-1Ea transcripts compared with normal fibroblasts. Class 2, IGF-1Eb forms were moderately expressed by fibroblasts only after stimulation with TGF-beta , which also further increased levels of Class 1, IGF-1Ea transcripts. Our findings suggest that transition from a healthy to a fibrotic phenotype occurs in association with a changing pattern of IGF-1 mRNA heterogeneity and leads us to hypothesize a potential role for specific IGF-1 variants in fibrogenesis.

Keywords: IGF-1; mRNA transcripts; idiopathic pulmonary fibrosis; pulmonary sarcoidosis; fibroblasts; competitive RT-PCR




This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
D. A. Schwartz
Genetic Analysis of Sporadic and Familial Interstitial Pneumonia
Proceedings of the ATS, April 15, 2008; 5(3): 343 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. K. Frankel, B. M. Moats-Staats, C. D. Cool, M. W. Wynes, A. D. Stiles, and D. W. H. Riches
Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L805 - L812.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. L. Watts and M. A. Spiteri
Connective tissue growth factor expression and induction by transforming growth factor-{beta} is abrogated by simvastatin via a Rho signaling mechanism
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1323 - L1332.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zhang, M. P. Keane, L. X. Zhu, S. Sharma, E. Rozengurt, R. M. Strieter, S. M. Dubinett, and M. Huang
Interleukin-7 and Transforming Growth Factor-{beta} Play Counter-regulatory Roles in Protein Kinase C-{delta}-dependent Control of Fibroblast Collagen Synthesis in Pulmonary Fibrosis
J. Biol. Chem., July 2, 2004; 279(27): 28315 - 28319.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. M. Krein, P. J. B. Sabatini, W. Tinmouth, F. H. Y. Green, and B. W. Winston
Localization of Insulin-like Growth Factor-I in Lung Tissues of Patients with Fibroproliferative Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 83 - 90.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. M. Krein and B. W. Winston
Roles for Insulin-Like Growth Factor I and Transforming Growth Factor-{beta} in Fibrotic Lung Disease
Chest, December 1, 2002; 122 (2009): 289S - 293S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Socioeconomic Issues in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 631 - 641.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  SOTA, FL